XML 27 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income (loss) $ 12 $ (4,927)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 708 1,028
Loss (gain) on disposal of property and equipment (67) (11)
Gains on sales of marketable securities (4) (12)
Grants recognized in other income and income from operations (397) (50)
Remeasurement of acquisition liabilities (5,080) 0
Stock compensation expense 685 519
Increase (decrease) in cash from:    
Accounts receivable 2,735 535
Inventory (133) 60
Prepaid expenses and other current assets 702 1,025
Research and development tax credit receivable (1,537) 347
Accounts payable 373 (463)
Deferred revenue (1,617) (886)
Accrued expenses (677) (1,283)
Other current liabilities 24 163
Other long-term assets and liabilities (312) (375)
Net cash provided by (used in) operating activities (4,585) (4,330)
Cash flows from investing activities:    
Purchases of property and equipment (336) (901)
Proceeds from disposal of property and equipment 67 11
Purchase of marketable securities (339) (3,689)
Proceeds from sales of marketable securities 3,618 7,985
Cash transferred on acquisition 1,631 0
Net cash provided by (used in) investing activities 4,641 3,406
Cash flows from financing activities:    
Proceeds from loan or conditional grants 170 0
Reimbursment of loans or conditional grants 0 (1,818)
Principal payments on capital lease obligations (31) (20)
Cash proceeds from issuance of ordinary shares and warrants 602 0
Net cash provided by (used in) financing activities 741 (1,838)
Effect of exchange rate changes on cash and cash equivalents 95 409
Net increase (decrease) in cash and cash equivalents 892 (2,353)
Cash and cash equivalents, beginning of period 3,456 8,184
Cash and cash equivalents, end of period 4,348 5,831
The supplemental schedule of non cash investing and financing activities is as follows    
Fair value of assets acquired: 50,927  
Liabilities assumed: $ 50,927